Pitcairn Co. Has $4.77 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Pitcairn Co. decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.5% during the 3rd quarter, Holdings Channel reports. The firm owned 10,667 shares of the medical equipment provider’s stock after selling 3,465 shares during the period. Pitcairn Co.’s holdings in Intuitive Surgical were worth $4,771,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Brighton Jones LLC increased its holdings in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the last quarter. Sivia Capital Partners LLC grew its position in shares of Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the period. Schnieders Capital Management LLC. increased its stake in shares of Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after purchasing an additional 268 shares during the last quarter. Versor Investments LP bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $325,000. Finally, Crestwood Advisors Group LLC raised its holdings in shares of Intuitive Surgical by 4.8% in the 2nd quarter. Crestwood Advisors Group LLC now owns 4,855 shares of the medical equipment provider’s stock valued at $2,638,000 after purchasing an additional 221 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock opened at $496.70 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The stock has a market capitalization of $176.39 billion, a price-to-earnings ratio of 62.95, a PEG ratio of 3.86 and a beta of 1.66. The business’s fifty day moving average price is $523.39 and its two-hundred day moving average price is $511.99.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period last year, the firm earned $2.21 earnings per share. Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the sale, the director owned 3,694 shares of the company’s stock, valued at $1,958,189.40. This represents a 86.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the transaction, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. This trade represents a 50.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 37,261 shares of company stock worth $19,690,721. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages have weighed in on ISRG. BTIG Research reissued a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research report on Friday, January 23rd. Barclays set a $712.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. Citigroup restated a “neutral” rating and issued a $590.00 price target (down from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Argus reduced their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Finally, HSBC increased their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research report on Monday, January 26th. Two analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $615.86.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands da Vinci 5 use to certain cardiac surgeries — broadens approved U.S. indications and could drive procedure volume and system utilization over time. Intuitive Surgical’s European Push And Cardiac Clearance Tested By Lofty Valuation
• Positive Sentiment: Direct operational expansion in Southern Europe (acquiring da Vinci and Ion distribution in Italy, Spain and Portugal) — could improve service, shorten sales cycles and capture more back-end revenue in key markets. Intuitive Surgical Expands Direct Operational Presence in Europe
• Positive Sentiment: My Intuitive+ could become a paid subscription in 2026 — potential new recurring, software-driven revenue stream that would diversify beyond systems and consumables. Can Digital Subscriptions Become ISRG’s New Revenue Stream in 2026?
• Neutral Sentiment: Positive publicity event: company rang the Nasdaq opening bell — PR visibility but limited direct financial impact. LIVE: Intuitive Surgical, Inc. Rings the Opening Bell
• Positive Sentiment: Analyst coverage: Zacks features ISRG as a top medical stock / strong-buy pick — analyst support can help sentiment and attract buyers. This Top Medical Stock is a #1 (Strong Buy)
• Negative Sentiment: Insider selling: Senior VP Mark Brosius sold multiple blocks of ISRG shares on Mar 3–5 (totaling several thousand shares and proceeds in the high six figures to low seven figures), materially reducing his holdings — can pressure sentiment when combined with other catalysts. SEC Filing – Insider Sales
• Negative Sentiment: Valuation concern flagged by coverage: some analysts note a “lofty valuation” that could limit upside despite product and geographic progress — makes the stock sensitive to execution and growth misses. Intuitive Surgical’s European Push And Cardiac Clearance Tested By Lofty Valuation

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.